Eli Lilly invites you to an insightful clinical session on optimizing the Alzheimer’s disease diagnostic pathway through the combined use of digital cognitive tests and blood tests. Featuring leading experts Dr. Kate Leppich, Prof. Dr.
Emrah Düzel, and Dr. Stephanie Daly, the session will explore how digital cognitive tools and blood tests can support earlier and more accurate identification of Alzheimer’s disease through real-world clinical cases. The experts will also discuss how blood tests can be integrated into routine clinical practice, how healthcare professionals can collaborate effectively across care settings, and how streamlined referral processes can support informed decision-making and timely access to specialist care. Join the experts on June 30 , 2026 , to gain practical insights into accelerating clinical decision-making and optimizing patient pathways for treatment…
